Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Distorted memories play role in preserving knowledge for dementia patients, researchers say

Some memories containing inaccurate information can be beneficial to dementia sufferers because it enables them to retain key information researchers say.

6 Mar 2018

Treatments targeted to enhance brain neurotrophic factor signaling may improve memory functions

Treatments targeted to enhance brain neurotrophic factor signaling could improve memory functions in Alzheimer's disease even though they don't alter brain amyloid burden, according to recent research from the University of Eastern Finland.

6 Mar 2018

AD polygenic risk score could identify younger population with mild cognitive impairment

For the first time, an international team of scientists, led by researchers at University of California San Diego School of Medicine, have determined that an Alzheimer's disease (AD) polygenic risk score can be used to correctly identify adults with mild cognitive impairment (MCI) who were only in their 50s. MCI is considered a precursor to AD.

5 Mar 2018

UAB scientists explore gene therapy for frontotemporal dementia

Gene therapy has shown promise for treating a neurodegenerative disease known as frontotemporal dementia and a related condition called neuronal ceroid lipofuscinosis, according to new findings presented in the Journal of Neuroscience by researchers from the University of Alabama at Birmingham.

1 Mar 2018

Traumatic brain injuries may increase risk of Alzheimer’s disease earlier in life

Concussions and other traumatic brain injuries may increase the risk of developing Alzheimer's disease earlier in life, according to a study from UT Southwestern's Peter O'Donnell Jr. Brain Institute.

1 Mar 2018

Gluten-free diet may help protect against neuropathic pain

A strict gluten-free diet may help protect against the nerve pain that some people with gluten sensitivity experience, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018.

1 Mar 2018

InSysBio evaluates tau protein phosphorylation related targets for treatment of AD

InSysBio continues to investigate the mechanisms underlying Alzheimer's disease using the quantitative systems pharmacology modeling approach. The part of QSP model describing tau protein was published in the PLOS ONE journal. This is one of more than dozen InSysBio publications in AD area during last seven years.

28 Feb 2018

Frequent exposure to diesel exhaust increases risk of ALS

People who are frequently exposed to diesel exhaust while on the job may have a higher risk of amyotrophic lateral sclerosis (ALS), and that risk may increase with greater exposure, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018.

28 Feb 2018

Study shows importance of family history in onset of Alzheimer's disease

You're about to turn 60, and you're fretting. Your mother has had Alzheimer's disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer's, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

27 Feb 2018

People with central hearing loss more likely to have mild cognitive impairment

Some people with a certain type of hearing loss may be more likely to also have the memory loss and thinking problems called mild cognitive impairment, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018. Hearing loss is one of the most common disabilities in elderly people, affecting about one-third of people over age 65.

27 Feb 2018

Trump’s perfect score on brain test spawns DIY cognitive exam

When Donald Trump aced a cognitive test in January, scores of people tried to take it, too, based mostly on media reports that invited them to match wits with the president.

26 Feb 2018

DASH diet may lower rates of depression over time

People who eat vegetables, fruit and whole grains may have lower rates of depression over time, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018.

26 Feb 2018

Tears may be reliable, noninvasive biological marker of Parkinson's disease

Tears may hold clues to whether someone has Parkinson's disease, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018.

24 Feb 2018

High protein diet reduces risk of Alzheimer’s disease, research finds

A diet high in protein-rich foods such as meat and legumes reduces the risk of developing Alzheimer’s disease, new research from Edith Cowan University has found.

23 Feb 2018

New intervention improves communication behaviors in couples affected by dementia

They do it with the best of intentions. "Do you remember our wedding day?" "Who is that person next to you in the picture?" For couples with decades of shared memories, a partner's decline in the ability to communicate is one of the most frightening and frustrating consequences of Alzheimer's disease and related dementias.

22 Feb 2018

MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage

Today, Ferring Pharmaceuticals and MSD, via its MSD for Mothers initiative, announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO).

22 Feb 2018

Researchers explore how people with Alzheimer's disease use end-of-life medical services

Because people are now living longer and often healthier lives, the rate of some illnesses that are more likely to develop with age has risen. These illnesses include dementia. In fact, the number of us living with dementia was already 47 million worldwide in 2015. It could reach 131 million by 2050.

22 Feb 2018

Study reveals biological relevance of sex in effects of D-galactose induced aging

A research study by the Universitat Autònoma de Barcelona in collaboration with the University of La Laguna demonstrates in mice the biological relevance of sex in the effects of accelerated ageing caused by a chronic treatment of D-galactose, a sugar found abundantly in milk and to a lesser extent in fruits and vegetables.

20 Feb 2018

AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies

AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.

20 Feb 2018

Study describes new protection mechanisms to fight neurodegeneration in Parkinson's and Alzheimer's

A new research study reveals RAC1 protein could be a new therapeutic target to study the molecular mechanisms related to the neurodegenerative processes in Parkinson's disease.

20 Feb 2018

Alzheimer's Disease News and Research

Further Reading

Distorted memories play role in preserving knowledge for dementia patients, researchers say

Treatments targeted to enhance brain neurotrophic factor signaling may improve memory functions

AD polygenic risk score could identify younger population with mild cognitive impairment

UAB scientists explore gene therapy for frontotemporal dementia

Traumatic brain injuries may increase risk of Alzheimer’s disease earlier in life

Gluten-free diet may help protect against neuropathic pain

InSysBio evaluates tau protein phosphorylation related targets for treatment of AD

Frequent exposure to diesel exhaust increases risk of ALS

Study shows importance of family history in onset of Alzheimer's disease

People with central hearing loss more likely to have mild cognitive impairment

Trump’s perfect score on brain test spawns DIY cognitive exam

DASH diet may lower rates of depression over time

Tears may be reliable, noninvasive biological marker of Parkinson's disease

High protein diet reduces risk of Alzheimer’s disease, research finds

New intervention improves communication behaviors in couples affected by dementia

MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage

Researchers explore how people with Alzheimer's disease use end-of-life medical services

Study reveals biological relevance of sex in effects of D-galactose induced aging

AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies

Study describes new protection mechanisms to fight neurodegeneration in Parkinson's and Alzheimer's

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News